£495.00

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in Japan

Subjects

Price data last checked 17 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£495 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 74 days · 74 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 74 days • 1 price levels

Days at Price

Price Analysis

Most common price: £495 (74 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 74 days

Description

This study covers the latent demand outlook for iron deficiency anemia therapies across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across over 1,000 cities in Japan. For each city in question, the percent share the city is of its prefecture and of Japan as a whole is reported. These comparative benchmarks allow the reader to quickly gauge a city vis-à-vis others. This statistical approach can prove very useful to distribution and/or sales force strategies. Using econometric models which project fundamental economic dynamics within each prefecture and city, latent demand estimates are created for iron deficiency anemia therapies. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. In this report we define the sales of iron deficiency anemia therapies as including all commonly understood products and/or services falling within this broad category, irrespective of product packaging, formulation, size, or form. Companies participating in this industry include AbbVie, Advanz Pharmaceutical, Akebia Therapeutics, Alkem Labs, Allergan, AMAG Pharmaceuticals, Avion Pharmaceuticals, CHO-A Pharmaceutical Company, Ltd., Fresenius Se & Company, GlaxoSmithKline, Hikma Pharmaceuticals, Johnson & Johnson, Keryx Biopharmaceuticals, Luitpold Pharmaceuticals, Lupin, Novartis, Orion, Pharmacosmos, Pieris Pharmaceuticals, Rockwell Medical, Sanofi, Shield Therapeutics, Teva Pharmaceutical Industries, ViforPharma, Ltd., and Zydus Cadila. In addition to the sources indicated, additional information available to the public via news and/or press releases published by players in the industry was considered in defining and calibrating this category. All figures are in a common currency (U.S. dollars, millions) and are not adjusted for inflation (i.e., they are current values). Exchange rates used to convert to U.S. dollars are averages for the year in question. Future exchange rates are assumed to be constant in the future at the current level (the average of the year of this publication's release in 2022).

Product Specifications

Format: paperback
ASIN: B0BP9SX992
Category: Books > Subjects
Domain: Amazon UK
Release Date: 28 November 2022
Listed Since: 08 December 2022

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in Japan

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Similar Products You Might Like

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in China

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in China

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in the United States

The 2023-2028 World Outlook for Iron Deficiency Anemia Therapies

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies in India

The 2023-2028 Outlook for Iron Deficiency Anemia Therapies for US Zip Codes

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in the United States

The 2023-2028 Outlook for Oral Iron Therapy for Iron Deficiency Anemia in the United States

The 2023-2028 Outlook for Oral Iron Therapy for Iron Deficiency Anemia in India

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs in India

The 2023-2028 Outlook for Iron Deficiency Anemia Drugs for US Zip Codes

The 2016-2021 Outlook for Iron Compounds Excluding Iron Oxides, Hydroxides, and Ferric Chloride in Africa

The 2016-2021 Outlook for Intravenous (IV) Iron Drugs in the United States

The 2023-2028 Outlook for Iron Drugs for US Zip Codes

The 2023-2028 Outlook for Oral Iron Drugs for US Zip Codes

The 2021-2026 World Outlook for Iron Compounds Excluding Iron Oxides, Hydroxides, and Ferric Chloride

Iron as Therapeutic Targets in Human Diseases: Volume 1

The 2016 Report on Iron Compounds Excluding Iron Oxides, Hydroxides, and Ferric Chloride: World Market Segmentation by City

The 2016 Import and Export Market for Iron Less Than 99.94% Pure or Steel Ingots and Other Primary Forms in Japan

The 2026-2031 World Outlook for Food Grade Iron Powders

The 2016 World Market Forecasts for Imported Iron Less Than 99.94% Pure or Steel Ingots and Other Primary Forms

The 2013 Import and Export Market for Iron Less Than 99.94% Pure or Steel Ingots and Other Primary Forms in Latin America

The 2016 World Market Forecasts for Imported Iron Less Than 99.94% Pure or Non-Alloy Steel in Primary Forms Excluding Ingots

The 2013 Import and Export Market for Iron Less Than 99.94% Pure or Steel Ingots and Other Primary Forms in Africa